Triple Combination Therapy Market to Surge to US$ 29.2 Billion by 2034, Growing at a 6.5% CAGR | Fact.MR Report
Adoption of Triple Combination Therapy Accelerates at Unprecedented Rates as Precision Medicine Revolution ContinuesRockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...
Retinal diseases: RNA therapeutics show promise but is India ready?
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
Alberta doctors warn obstetrician-gynecologist shortage could mean more preemies
Alberta Medical Association warns that shortage of obstetricians, gynecologists could have negative impact on mothers, babies ...
Edmonton Journal3h
Thousands of women and babies at risk from OBGYN shortages: Alberta doctors
A new report released by the Alberta Medical Association says the number of Albertans without primary care, combined with ...
Hosted on MSN20h
BTIG Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Buy Recommendation
Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy ...
4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...
From Underperformance To Opportunity: Biotech's Case For 2025
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...